医薬品分離＆封じ込めシステムのグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Pharmaceutical Isolating and Containment Systems Market Insights and Forecast to 2027

• レポートコード：QY2112C03651 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療装置

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料は医薬品分離＆封じ込めシステムの世界市場の現状について調査・分析し、2027年までの市場を予測しました。医薬品分離＆封じ込めシステムの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（生産分離＆封じ込めシステム、試験分離＆封じ込めシステム）、用途別市場規模（学術研究機関、製薬・バイオテクノロジー企業、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・医薬品分離＆封じ込めシステムの世界市場概要 ・メーカー別の競争状況、市場シェア ・医薬品分離＆封じ込めシステムの種類別市場規模：生産分離＆封じ込めシステム、試験分離＆封じ込めシステム ・医薬品分離＆封じ込めシステムの用途別市場規模：学術研究機関、製薬・バイオテクノロジー企業、その他 ・北米の医薬品分離＆封じ込めシステム市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの医薬品分離＆封じ込めシステム市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの医薬品分離＆封じ込めシステム市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の医薬品分離＆封じ込めシステム市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの医薬品分離＆封じ込めシステム市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：SKAN、Extract Technology、Bioquell、Tofflon、Getinge、Syntegon、Comecer、ISOTECH、Weike、Azbil Telstar、Fedegari Autoclavi、Hosokawa Micron ・医薬品分離＆封じ込めシステムのバリューチェーン・販売チャネル分析 ・医薬品分離＆封じ込めシステムの世界市場動向

Market Analysis and Insights: Global Pharmaceutical Isolating and Containment Systems Market
The global Pharmaceutical Isolating and Containment Systems market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.

Global Pharmaceutical Isolating and Containment Systems Scope and Segment
Pharmaceutical Isolating and Containment Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Isolating and Containment Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Production Isolating and Containment Systems
Testing Isolating and Containment Systems

Segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Others

By Company
SKAN
Extract Technology
Bioquell
Tofflon
Getinge
Syntegon
Comecer
ISOTECH
Weike
Azbil Telstar
Fedegari Autoclavi
Hosokawa Micron

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Pharmaceutical Isolating and Containment Systems Product Introduction
1.2 Market by Type
1.2.1 Global Pharmaceutical Isolating and Containment Systems Market Size Growth Rate by Type
1.2.2 Production Isolating and Containment Systems
1.2.3 Testing Isolating and Containment Systems
1.3 Market by Application
1.3.1 Global Pharmaceutical Isolating and Containment Systems Market Size Growth Rate by Application
1.3.2 Academic and Research Institutes
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Pharmaceutical Isolating and Containment Systems Sales Estimates and Forecasts 2016-2027
2.2 Global Pharmaceutical Isolating and Containment Systems Revenue Estimates and Forecasts 2016-2027
2.3 Global Pharmaceutical Isolating and Containment Systems Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Pharmaceutical Isolating and Containment Systems Regions by Sales
2.4.1 Global Top Pharmaceutical Isolating and Containment Systems Regions by Sales (2016-2021)
2.4.2 Global Top Pharmaceutical Isolating and Containment Systems Regions by Sales (2022-2027)
2.5 Global Top Pharmaceutical Isolating and Containment Systems Regions by Revenue
2.5.1 Global Top Pharmaceutical Isolating and Containment Systems Regions by Revenue (2016-2021)
2.5.2 Global Top Pharmaceutical Isolating and Containment Systems Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Pharmaceutical Isolating and Containment Systems Sales by Manufacturers
3.1.1 Global Top Pharmaceutical Isolating and Containment Systems Manufacturers by Sales (2016-2021)
3.1.2 Global Top Pharmaceutical Isolating and Containment Systems Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Pharmaceutical Isolating and Containment Systems Sales in 2020
3.2 Global Pharmaceutical Isolating and Containment Systems Revenue by Manufacturers
3.2.1 Global Top Pharmaceutical Isolating and Containment Systems Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Pharmaceutical Isolating and Containment Systems Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Pharmaceutical Isolating and Containment Systems Revenue in 2020
3.3 Global Pharmaceutical Isolating and Containment Systems Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pharmaceutical Isolating and Containment Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pharmaceutical Isolating and Containment Systems Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Pharmaceutical Isolating and Containment Systems Sales by Type
4.1.1 Global Pharmaceutical Isolating and Containment Systems Historical Sales by Type (2016-2021)
4.1.2 Global Pharmaceutical Isolating and Containment Systems Forecasted Sales by Type (2022-2027)
4.1.3 Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2016-2027)
4.2 Global Pharmaceutical Isolating and Containment Systems Revenue by Type
4.2.1 Global Pharmaceutical Isolating and Containment Systems Historical Revenue by Type (2016-2021)
4.2.2 Global Pharmaceutical Isolating and Containment Systems Forecasted Revenue by Type (2022-2027)
4.2.3 Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Type (2016-2027)
4.3 Global Pharmaceutical Isolating and Containment Systems Price by Type
4.3.1 Global Pharmaceutical Isolating and Containment Systems Price by Type (2016-2021)
4.3.2 Global Pharmaceutical Isolating and Containment Systems Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Pharmaceutical Isolating and Containment Systems Sales by Application
5.1.1 Global Pharmaceutical Isolating and Containment Systems Historical Sales by Application (2016-2021)
5.1.2 Global Pharmaceutical Isolating and Containment Systems Forecasted Sales by Application (2022-2027)
5.1.3 Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2016-2027)
5.2 Global Pharmaceutical Isolating and Containment Systems Revenue by Application
5.2.1 Global Pharmaceutical Isolating and Containment Systems Historical Revenue by Application (2016-2021)
5.2.2 Global Pharmaceutical Isolating and Containment Systems Forecasted Revenue by Application (2022-2027)
5.2.3 Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Application (2016-2027)
5.3 Global Pharmaceutical Isolating and Containment Systems Price by Application
5.3.1 Global Pharmaceutical Isolating and Containment Systems Price by Application (2016-2021)
5.3.2 Global Pharmaceutical Isolating and Containment Systems Price Forecast by Application (2022-2027)

6 North America
6.1 North America Pharmaceutical Isolating and Containment Systems Market Size by Type
6.1.1 North America Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2027)
6.1.2 North America Pharmaceutical Isolating and Containment Systems Revenue by Type (2016-2027)
6.2 North America Pharmaceutical Isolating and Containment Systems Market Size by Application
6.2.1 North America Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2027)
6.2.2 North America Pharmaceutical Isolating and Containment Systems Revenue by Application (2016-2027)
6.3 North America Pharmaceutical Isolating and Containment Systems Market Size by Country
6.3.1 North America Pharmaceutical Isolating and Containment Systems Sales by Country (2016-2027)
6.3.2 North America Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Pharmaceutical Isolating and Containment Systems Market Size by Type
7.1.1 Europe Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2027)
7.1.2 Europe Pharmaceutical Isolating and Containment Systems Revenue by Type (2016-2027)
7.2 Europe Pharmaceutical Isolating and Containment Systems Market Size by Application
7.2.1 Europe Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2027)
7.2.2 Europe Pharmaceutical Isolating and Containment Systems Revenue by Application (2016-2027)
7.3 Europe Pharmaceutical Isolating and Containment Systems Market Size by Country
7.3.1 Europe Pharmaceutical Isolating and Containment Systems Sales by Country (2016-2027)
7.3.2 Europe Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Pharmaceutical Isolating and Containment Systems Market Size by Type
8.1.1 Asia Pacific Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2027)
8.1.2 Asia Pacific Pharmaceutical Isolating and Containment Systems Revenue by Type (2016-2027)
8.2 Asia Pacific Pharmaceutical Isolating and Containment Systems Market Size by Application
8.2.1 Asia Pacific Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2027)
8.2.2 Asia Pacific Pharmaceutical Isolating and Containment Systems Revenue by Application (2016-2027)
8.3 Asia Pacific Pharmaceutical Isolating and Containment Systems Market Size by Region
8.3.1 Asia Pacific Pharmaceutical Isolating and Containment Systems Sales by Region (2016-2027)
8.3.2 Asia Pacific Pharmaceutical Isolating and Containment Systems Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Pharmaceutical Isolating and Containment Systems Market Size by Type
9.1.1 Latin America Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2027)
9.1.2 Latin America Pharmaceutical Isolating and Containment Systems Revenue by Type (2016-2027)
9.2 Latin America Pharmaceutical Isolating and Containment Systems Market Size by Application
9.2.1 Latin America Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2027)
9.2.2 Latin America Pharmaceutical Isolating and Containment Systems Revenue by Application (2016-2027)
9.3 Latin America Pharmaceutical Isolating and Containment Systems Market Size by Country
9.3.1 Latin America Pharmaceutical Isolating and Containment Systems Sales by Country (2016-2027)
9.3.2 Latin America Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Pharmaceutical Isolating and Containment Systems Market Size by Type
10.1.1 Middle East and Africa Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2027)
10.1.2 Middle East and Africa Pharmaceutical Isolating and Containment Systems Revenue by Type (2016-2027)
10.2 Middle East and Africa Pharmaceutical Isolating and Containment Systems Market Size by Application
10.2.1 Middle East and Africa Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2027)
10.2.2 Middle East and Africa Pharmaceutical Isolating and Containment Systems Revenue by Application (2016-2027)
10.3 Middle East and Africa Pharmaceutical Isolating and Containment Systems Market Size by Country
10.3.1 Middle East and Africa Pharmaceutical Isolating and Containment Systems Sales by Country (2016-2027)
10.3.2 Middle East and Africa Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 SKAN
11.1.1 SKAN Corporation Information
11.1.2 SKAN Overview
11.1.3 SKAN Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 SKAN Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 SKAN Recent Developments
11.2 Extract Technology
11.2.1 Extract Technology Corporation Information
11.2.2 Extract Technology Overview
11.2.3 Extract Technology Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Extract Technology Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Extract Technology Recent Developments
11.3 Bioquell
11.3.1 Bioquell Corporation Information
11.3.2 Bioquell Overview
11.3.3 Bioquell Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Bioquell Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bioquell Recent Developments
11.4 Tofflon
11.4.1 Tofflon Corporation Information
11.4.2 Tofflon Overview
11.4.3 Tofflon Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Tofflon Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Tofflon Recent Developments
11.5 Getinge
11.5.1 Getinge Corporation Information
11.5.2 Getinge Overview
11.5.3 Getinge Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Getinge Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Getinge Recent Developments
11.6 Syntegon
11.6.1 Syntegon Corporation Information
11.6.2 Syntegon Overview
11.6.3 Syntegon Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Syntegon Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Syntegon Recent Developments
11.7 Comecer
11.7.1 Comecer Corporation Information
11.7.2 Comecer Overview
11.7.3 Comecer Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Comecer Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Comecer Recent Developments
11.8 ISOTECH
11.8.1 ISOTECH Corporation Information
11.8.2 ISOTECH Overview
11.8.3 ISOTECH Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 ISOTECH Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 ISOTECH Recent Developments
11.9 Weike
11.9.1 Weike Corporation Information
11.9.2 Weike Overview
11.9.3 Weike Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Weike Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Weike Recent Developments
11.10 Azbil Telstar
11.10.1 Azbil Telstar Corporation Information
11.10.2 Azbil Telstar Overview
11.10.3 Azbil Telstar Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Azbil Telstar Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Azbil Telstar Recent Developments
11.11 Fedegari Autoclavi
11.11.1 Fedegari Autoclavi Corporation Information
11.11.2 Fedegari Autoclavi Overview
11.11.3 Fedegari Autoclavi Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Fedegari Autoclavi Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Fedegari Autoclavi Recent Developments
11.12 Hosokawa Micron
11.12.1 Hosokawa Micron Corporation Information
11.12.2 Hosokawa Micron Overview
11.12.3 Hosokawa Micron Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Hosokawa Micron Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Hosokawa Micron Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Pharmaceutical Isolating and Containment Systems Value Chain Analysis
12.2 Pharmaceutical Isolating and Containment Systems Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pharmaceutical Isolating and Containment Systems Production Mode & Process
12.4 Pharmaceutical Isolating and Containment Systems Sales and Marketing
12.4.1 Pharmaceutical Isolating and Containment Systems Sales Channels
12.4.2 Pharmaceutical Isolating and Containment Systems Distributors
12.5 Pharmaceutical Isolating and Containment Systems Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pharmaceutical Isolating and Containment Systems Industry Trends
13.2 Pharmaceutical Isolating and Containment Systems Market Drivers
13.3 Pharmaceutical Isolating and Containment Systems Market Challenges
13.4 Pharmaceutical Isolating and Containment Systems Market Restraints

14 Key Findings in The Global Pharmaceutical Isolating and Containment Systems Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Pharmaceutical Isolating and Containment Systems Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Production Isolating and Containment Systems
Table 3. Major Manufacturers of Testing Isolating and Containment Systems
Table 4. Global Pharmaceutical Isolating and Containment Systems Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Pharmaceutical Isolating and Containment Systems Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Pharmaceutical Isolating and Containment Systems Sales by Region (2016-2021) & (K Units)
Table 7. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Region (2016-2021)
Table 8. Global Pharmaceutical Isolating and Containment Systems Sales by Region (2022-2027) & (K Units)
Table 9. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Region (2022-2027)
Table 10. Global Pharmaceutical Isolating and Containment Systems Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Region (2016-2021)
Table 12. Global Pharmaceutical Isolating and Containment Systems Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Region (2022-2027)
Table 14. Global Pharmaceutical Isolating and Containment Systems Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Pharmaceutical Isolating and Containment Systems Sales Share by Manufacturers (2016-2021)
Table 16. Global Pharmaceutical Isolating and Containment Systems Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Pharmaceutical Isolating and Containment Systems Revenue Share by Manufacturers (2016-2021)
Table 18. Pharmaceutical Isolating and Containment Systems Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Pharmaceutical Isolating and Containment Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Pharmaceutical Isolating and Containment Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Isolating and Containment Systems as of 2020)
Table 21. Pharmaceutical Isolating and Containment Systems Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Pharmaceutical Isolating and Containment Systems Product Offered
Table 23. Date of Manufacturers Enter into Pharmaceutical Isolating and Containment Systems Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2021) & (K Units)
Table 26. Global Pharmaceutical Isolating and Containment Systems Sales by Type (2022-2027) & (K Units)
Table 27. Global Pharmaceutical Isolating and Containment Systems Sales Share by Type (2016-2021)
Table 28. Global Pharmaceutical Isolating and Containment Systems Sales Share by Type (2022-2027)
Table 29. Global Pharmaceutical Isolating and Containment Systems Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Pharmaceutical Isolating and Containment Systems Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Pharmaceutical Isolating and Containment Systems Revenue Share by Type (2016-2021)
Table 32. Global Pharmaceutical Isolating and Containment Systems Revenue Share by Type (2022-2027)
Table 33. Pharmaceutical Isolating and Containment Systems Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Pharmaceutical Isolating and Containment Systems Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2021) & (K Units)
Table 36. Global Pharmaceutical Isolating and Containment Systems Sales by Application (2022-2027) & (K Units)
Table 37. Global Pharmaceutical Isolating and Containment Systems Sales Share by Application (2016-2021)
Table 38. Global Pharmaceutical Isolating and Containment Systems Sales Share by Application (2022-2027)
Table 39. Global Pharmaceutical Isolating and Containment Systems Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Pharmaceutical Isolating and Containment Systems Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Pharmaceutical Isolating and Containment Systems Revenue Share by Application (2016-2021)
Table 42. Global Pharmaceutical Isolating and Containment Systems Revenue Share by Application (2022-2027)
Table 43. Pharmaceutical Isolating and Containment Systems Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Pharmaceutical Isolating and Containment Systems Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2021) & (K Units)
Table 46. North America Pharmaceutical Isolating and Containment Systems Sales by Type (2022-2027) & (K Units)
Table 47. North America Pharmaceutical Isolating and Containment Systems Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Pharmaceutical Isolating and Containment Systems Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2021) & (K Units)
Table 50. North America Pharmaceutical Isolating and Containment Systems Sales by Application (2022-2027) & (K Units)
Table 51. North America Pharmaceutical Isolating and Containment Systems Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Pharmaceutical Isolating and Containment Systems Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Pharmaceutical Isolating and Containment Systems Sales by Country (2016-2021) & (K Units)
Table 54. North America Pharmaceutical Isolating and Containment Systems Sales by Country (2022-2027) & (K Units)
Table 55. North America Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Pharmaceutical Isolating and Containment Systems Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2021) & (K Units)
Table 58. Europe Pharmaceutical Isolating and Containment Systems Sales by Type (2022-2027) & (K Units)
Table 59. Europe Pharmaceutical Isolating and Containment Systems Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Pharmaceutical Isolating and Containment Systems Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2021) & (K Units)
Table 62. Europe Pharmaceutical Isolating and Containment Systems Sales by Application (2022-2027) & (K Units)
Table 63. Europe Pharmaceutical Isolating and Containment Systems Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Pharmaceutical Isolating and Containment Systems Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Pharmaceutical Isolating and Containment Systems Sales by Country (2016-2021) & (K Units)
Table 66. Europe Pharmaceutical Isolating and Containment Systems Sales by Country (2022-2027) & (K Units)
Table 67. Europe Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Pharmaceutical Isolating and Containment Systems Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Pharmaceutical Isolating and Containment Systems Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Pharmaceutical Isolating and Containment Systems Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Pharmaceutical Isolating and Containment Systems Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Pharmaceutical Isolating and Containment Systems Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Pharmaceutical Isolating and Containment Systems Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Pharmaceutical Isolating and Containment Systems Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Pharmaceutical Isolating and Containment Systems Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Pharmaceutical Isolating and Containment Systems Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Pharmaceutical Isolating and Containment Systems Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Pharmaceutical Isolating and Containment Systems Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Pharmaceutical Isolating and Containment Systems Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Pharmaceutical Isolating and Containment Systems Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Pharmaceutical Isolating and Containment Systems Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Pharmaceutical Isolating and Containment Systems Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Pharmaceutical Isolating and Containment Systems Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Pharmaceutical Isolating and Containment Systems Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Pharmaceutical Isolating and Containment Systems Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Pharmaceutical Isolating and Containment Systems Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Pharmaceutical Isolating and Containment Systems Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Pharmaceutical Isolating and Containment Systems Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Pharmaceutical Isolating and Containment Systems Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Pharmaceutical Isolating and Containment Systems Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Pharmaceutical Isolating and Containment Systems Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Pharmaceutical Isolating and Containment Systems Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Pharmaceutical Isolating and Containment Systems Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Pharmaceutical Isolating and Containment Systems Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Pharmaceutical Isolating and Containment Systems Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Pharmaceutical Isolating and Containment Systems Revenue by Country (2022-2027) & (US$ Million)
Table 105. SKAN Corporation Information
Table 106. SKAN Description and Major Businesses
Table 107. SKAN Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. SKAN Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. SKAN Recent Developments
Table 110. Extract Technology Corporation Information
Table 111. Extract Technology Description and Major Businesses
Table 112. Extract Technology Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Extract Technology Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Extract Technology Recent Developments
Table 115. Bioquell Corporation Information
Table 116. Bioquell Description and Major Businesses
Table 117. Bioquell Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Bioquell Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Bioquell Recent Developments
Table 120. Tofflon Corporation Information
Table 121. Tofflon Description and Major Businesses
Table 122. Tofflon Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Tofflon Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Tofflon Recent Developments
Table 125. Getinge Corporation Information
Table 126. Getinge Description and Major Businesses
Table 127. Getinge Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Getinge Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Getinge Recent Developments
Table 130. Syntegon Corporation Information
Table 131. Syntegon Description and Major Businesses
Table 132. Syntegon Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Syntegon Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Syntegon Recent Developments
Table 135. Comecer Corporation Information
Table 136. Comecer Description and Major Businesses
Table 137. Comecer Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Comecer Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Comecer Recent Developments
Table 140. ISOTECH Corporation Information
Table 141. ISOTECH Description and Major Businesses
Table 142. ISOTECH Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. ISOTECH Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. ISOTECH Recent Developments
Table 145. Weike Corporation Information
Table 146. Weike Description and Major Businesses
Table 147. Weike Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 148. Weike Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Weike Recent Developments
Table 150. Azbil Telstar Corporation Information
Table 151. Azbil Telstar Description and Major Businesses
Table 152. Azbil Telstar Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 153. Azbil Telstar Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Azbil Telstar Recent Developments
Table 155. Fedegari Autoclavi Corporation Information
Table 156. Fedegari Autoclavi Description and Major Businesses
Table 157. Fedegari Autoclavi Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. Fedegari Autoclavi Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Fedegari Autoclavi Recent Developments
Table 160. Hosokawa Micron Corporation Information
Table 161. Hosokawa Micron Description and Major Businesses
Table 162. Hosokawa Micron Pharmaceutical Isolating and Containment Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 163. Hosokawa Micron Pharmaceutical Isolating and Containment Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Hosokawa Micron Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Pharmaceutical Isolating and Containment Systems Distributors List
Table 168. Pharmaceutical Isolating and Containment Systems Customers List
Table 169. Pharmaceutical Isolating and Containment Systems Market Trends
Table 170. Pharmaceutical Isolating and Containment Systems Market Drivers
Table 171. Pharmaceutical Isolating and Containment Systems Market Challenges
Table 172. Pharmaceutical Isolating and Containment Systems Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Isolating and Containment Systems Product Picture
Figure 3. Global Pharmaceutical Isolating and Containment Systems Market Share by Type in 2020 & 2027
Figure 3. Production Isolating and Containment Systems Product Picture
Figure 4. Testing Isolating and Containment Systems Product Picture
Figure 5. Global Pharmaceutical Isolating and Containment Systems Market Share by Application in 2020 & 2027
Figure 6. Academic and Research Institutes
Figure 7. Pharmaceutical and Biotechnology Companies
Figure 8. Others
Figure 9. Pharmaceutical Isolating and Containment Systems Report Years Considered
Figure 10. Global Pharmaceutical Isolating and Containment Systems Sales 2016-2027 (K Units)
Figure 11. Global Pharmaceutical Isolating and Containment Systems Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pharmaceutical Isolating and Containment Systems Revenue 2016-2027 (US$ Million)
Figure 13. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Region (2016-2021)
Figure 15. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Region (2022-2027)
Figure 16. North America Pharmaceutical Isolating and Containment Systems Sales YoY (2016-2027) & (K Units)
Figure 17. North America Pharmaceutical Isolating and Containment Systems Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Pharmaceutical Isolating and Containment Systems Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Pharmaceutical Isolating and Containment Systems Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Pharmaceutical Isolating and Containment Systems Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Pharmaceutical Isolating and Containment Systems Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Pharmaceutical Isolating and Containment Systems Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Pharmaceutical Isolating and Containment Systems Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Pharmaceutical Isolating and Containment Systems Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Pharmaceutical Isolating and Containment Systems Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Pharmaceutical Isolating and Containment Systems Revenue in 2020
Figure 28. Pharmaceutical Isolating and Containment Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2016-2027)
Figure 30. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Type (2016-2027)
Figure 31. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2016-2027)
Figure 32. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Application (2016-2027)
Figure 33. North America Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2016-2027)
Figure 34. North America Pharmaceutical Isolating and Containment Systems Revenue Market Share by Type (2016-2027)
Figure 35. North America Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2016-2027)
Figure 36. North America Pharmaceutical Isolating and Containment Systems Revenue Market Share by Application (2016-2027)
Figure 37. North America Pharmaceutical Isolating and Containment Systems Sales Share by Country (2016-2027)
Figure 38. North America Pharmaceutical Isolating and Containment Systems Revenue Share by Country (2016-2027)
Figure 39. United States Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2016-2027)
Figure 42. Europe Pharmaceutical Isolating and Containment Systems Revenue Market Share by Type (2016-2027)
Figure 43. Europe Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2016-2027)
Figure 44. Europe Pharmaceutical Isolating and Containment Systems Revenue Market Share by Application (2016-2027)
Figure 45. Europe Pharmaceutical Isolating and Containment Systems Sales Share by Country (2016-2027)
Figure 46. Europe Pharmaceutical Isolating and Containment Systems Revenue Share by Country (2016-2027)
Figure 47. Germany Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 48. France Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Pharmaceutical Isolating and Containment Systems Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Pharmaceutical Isolating and Containment Systems Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Pharmaceutical Isolating and Containment Systems Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Pharmaceutical Isolating and Containment Systems Revenue Share by Region (2016-2027)
Figure 58. China Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 61. India Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 63. China Taiwan Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2016-2027)
Figure 68. Latin America Pharmaceutical Isolating and Containment Systems Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2016-2027)
Figure 70. Latin America Pharmaceutical Isolating and Containment Systems Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Pharmaceutical Isolating and Containment Systems Sales Share by Country (2016-2027)
Figure 72. Latin America Pharmaceutical Isolating and Containment Systems Revenue Share by Country (2016-2027)
Figure 73. Mexico Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 76. Colombia Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Pharmaceutical Isolating and Containment Systems Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Pharmaceutical Isolating and Containment Systems Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Pharmaceutical Isolating and Containment Systems Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Pharmaceutical Isolating and Containment Systems Revenue Share by Country (2016-2027)
Figure 83. Turkey Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Pharmaceutical Isolating and Containment Systems Revenue (2016-2027) & (US$ Million)
Figure 86. Pharmaceutical Isolating and Containment Systems Value Chain
Figure 87. Pharmaceutical Isolating and Containment Systems Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---